Soturi
Development- Indications
- Parkinson's disease
Company intelligence / Profile preview
Newel Health develops and commercializes clinically validated digital therapeutics. Its Amicomed app for hypertension has received CE mark certification under the European Medical Device Regulation as a class IIa medical device, supporting its use in clinical practice. The company’s Soturi program for Parkinson’s disease management leverages AI-driven decision support and wearable sensors, with ongoing clinical validation supported by funding from The Michael J. Fox Foundation.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Newel Health.